Adverse effects of latanoprost on patients with medically resistant glaucoma

Archives of Ophthalmology

Volumn 116, Issue 5, 1998, Pages 679-680

  Avakian, Arpenik ^a   Renier, Sharon Anderson ^a   Butler, Patrick J ^a,b  

^a Prairie Eye Center ^*

^b Prairie Eye Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETAXOLOL; DICLOFENAC; LATANOPROST; PILOCARPINE; TIMOLOL MALEATE;

AGED; ARTICLE; CASE REPORT; FEMALE; HUMAN; OPEN ANGLE GLAUCOMA; PRIORITY JOURNAL; RETINA MACULA CYSTOID EDEMA; TOPICAL DRUG ADMINISTRATION; VISUAL ACUITY;

AGED; AGED, 80 AND OVER; FEMALE; GLAUCOMA, OPEN-ANGLE; HUMANS; MACULAR EDEMA, CYSTOID; PROSTAGLANDINS F, SYNTHETIC;

EID: 0031695624     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (2)

1. Woodward DR, Regan JW, Lake, Oakline A. The molecular biology and ocular distribution of prostanoid receptors. Surv Ophthalmol 1997;41 (suppl 2)S15-S21.
2. Hoyng PFJ, Rulo AH, Greve EL, et al. Fluorescein angiographic evaluation of the effect of latanoprost treatment on blood retinal barrier integrity: a review of studies conducted on phakic and aphakic monkeys. Surv Ophthalmol. 1997;41(suppl 2):S83-S88.